Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET/CT Assessment of Myocardial Blood Flow in ICI Therapy
NCT04538950Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Aug 2020
- Primary completion
- May 2022
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in cancer, sponsored by Mayo Clinic. Primary endpoint: Microvascular Damage/Endothelial Dysfunction at 6 weeks. Started Aug 2020; status: completed.
02
Conditions
cancer
Beyond the preview
Go deeper on NCT04538950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04538950.